LianBio American Depositary Shares
LIAN
LIAN was delisted on the 18th of March, 2024.
44 hedge funds and large institutions have $187M invested in LianBio American Depositary Shares in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 6 closing their positions.
117% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 6
19% more funds holding
Funds holding: 37 → 44 (+7)
10% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 10
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.15% less ownership
Funds ownership: 80.15% → 79.99% (-0.15%)
41% less capital invested
Capital invested by funds: $319M → $187M (-$132M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$7.01M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$3.5M |
| 3 |
BlackRock
New York
|
+$3.5M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$1.7M |
| 5 |
ACM
Altium Capital Management
New York
|
+$1.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$10.3M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$5.12M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.02M |
| 4 |
LCM
Laurion Capital Management
New York
|
-$742K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$392K |
LIAN Hedge Fund Activity: Q2 2022 in Review
44 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in LianBio American Depositary Shares (LIAN) for Q2 2022, worth a combined $187M — down 41% from $319M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new LIAN positions and 6 closed out — a net gain of 7 holders — while 11 added to existing stakes and 10 trimmed.
The largest buyer was Viking Global Investors, adding an estimated $7.01M. The largest seller was RA Capital Management, cutting an estimated $10.3M.
- 44 institutional investors held LianBio American Depositary Shares (LIAN) as of Q2 2022, up from 37 in Q1 2022.
- Funds reported $187M of LianBio American Depositary Shares stock for Q2 2022, down 41% quarter-over-quarter.
- 13 funds opened new LianBio American Depositary Shares positions in Q2 2022 and 6 closed out, a net change of +7 holders.
- The largest LianBio American Depositary Shares buyer in Q2 2022 was Viking Global Investors, an estimated $7.01M added.
- The largest LianBio American Depositary Shares seller in Q2 2022 was RA Capital Management, an estimated $10.3M sold.
Based on aggregated 13F filings for Q2 2022.